CSL (OTCMKTS:CSLLY) Share Price Breaks Above 50 Day Moving Average – Here’s What Happened

CSL Limited Sponsored ADR (OTCMKTS:CSLLY – Get Free Report)’s share price crossed above its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $32.95 and traded as high as $33.35. CSL shares last traded at $33.01, with a volume of 1,943,131 shares changing hands.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on CSLLY shares. Zacks Research upgraded CSL from a “strong sell” rating to a “hold” rating in a research note on Friday, August 7th. Royal Bank Of Canada upgraded CSL from a “hold” rating to a “moderate buy” rating in a research report on Tuesday, September 15th. One research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold”.

View Our Latest Stock Report on CSL

CSL Stock Up 0.3%

The company has a current ratio of 2.21, a quick ratio of 0.97 and a debt-to-equity ratio of 0.60. The business’s fifty day simple moving average is $32.95 and its 200-day simple moving average is $28.45.

CSL Company Profile

(Get Free Report)

CSL Limited is an Australian biotechnology company that develops and manufactures medicines and vaccines for people with serious and rare conditions. Its businesses include CSL Behring, which produces plasma-derived and recombinant therapies; CSL Seqirus, a developer of influenza vaccines and other related products; and CSL Vifor, which focuses on iron deficiency and kidney and related diseases. CSL’s treatments address areas including bleeding disorders, immune deficiencies and respiratory conditions.

Further Reading

Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.